Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes studyRUTHERFORD, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: ...

Glucotrack (GCTK) will participate in the FORGETDIABETES bionic pancreas initiative that will develop a long-term, automated insulin delivery ...

Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.

GlucoTrack presents a dashboard that displays patterns in glucose readings and provides feedback intended to inform users’ decisions regarding diet, exercise, and medication. The platform ...

This data feed is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

John Hennessey, company founder and CEO: "During the past three years we've delivered nearly 30 F5's to clients all around ...

K Street is still digesting the 90-day pause on Trump’s so-called reciprocal tariffs to chart the best path forward for clients over the next three months.